Lewis C. Becker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lewis C. Becker has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Dhananjay Vaidya
Department of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine , Baltimore, MD 21205
4 shared publications Xiao Ping Yang
Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205
4 shared publications- Diane M. Becker
Johns Hopkins, Baltimore, MD
3 shared publications - Kaikobad Irani
Division of Cardiovascular Medicine, University of Iowa Carver College of Medicine, Iowa City, USA
3 shared publications - Lisa R. Yanek
Johns Hopkins University School of Medicine
3 shared publications - Brian G. Kral
Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, USA
2 shared publications
Latest Publications
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WP413: White Matter Tract Disruption on Diffusor Tensor Imaging is Associated With Serum Ceramides in a Healthy Middle-Aged High Risk Population
Introduction: White matter tract disruption (WMTD) on Diffusion Tensor Imaging (DTI) may reflect early axonal disruption and tract injury and identify risk for dementia. Brain ceramides play a role in processes also associated with dementia risk. We hypothesized that circulating ceramide levels might serve as biomarkers of WMTD in a population at high risk for early vascular disease. We studied six ceramides and WMTD using fractional anisotropy (FA) on DTI in healthy relatives of patients with early coronary disease. We have previously shown a high prevalence of white matter hyperintensities (WMH) and significant associations between WMH volumes, FA, and lower cognitive function in healthy relatives. Methods: DTI was acquired with Phillips 3T MRI. FA was measured for 181 regions of the segmented brain using Eve atlas. 48 relevant regions with susceptibility for WMTD were analyzed. Serum ceramides were measured using high performance liquid chromatography. Spearman correlations and GEE linear regression analyses (adjusted for age, sex, race, education and family relatedness) were used. We set the significance level to meet the Bonferroni threshold of 0.00017 (0.05 / 48 regions/6 ceramides). Results: Subjects, N=112, had a mean age of 49± 11 years; education 14 ± 3 years; 49% male; 39% African American, 61% European American). Serum levels for ceramides designated C18:0, C20:0, and C22:0 were significantly negatively correlated with FA in the right fornix (C18:0, R=-0.40, p=1.3 x10 -5 , C20:0, R=-0.41, p= 6.1 x 10 -6 , C22:0, R=-0.33, p=4.3 x10 -4 ). C18:0 was negatively correlated with the left genu of corpus callosum (R=-0.39, p=2.6 x10 -5 ) and right body of corpus callosum (R=-0.31, p=8.5 x10 -4 ). An additional ceramide, C24:0, was correlated with both sides of the posterior limb of internal capsule (left R=0.34, p=2.5 x10 -4 ; right R=0.34, p=2.8 x10 -4 ). All ceramide-FA associations were significant (pConclusions: We show a robust relationship between serum ceramides and WMTD using FA in a middle-aged, cognitively intact at-risk population enriched for early WMH. Thus, serum ceramide levels may reflect subtle alterations in white matter tract microstructure at an early preclinical stage.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WP413: White Matter Tract Disruption on Diffusor Tensor Imaging is Associated With Serum Ceramides in a Healthy Middle-Aged High Risk Population
Introduction: White matter tract disruption (WMTD) on Diffusion Tensor Imaging (DTI) may reflect early axonal disruption and tract injury and identify risk for dementia. Brain ceramides play a role in processes also associated with dementia risk. We hypothesized that circulating ceramide levels might serve as biomarkers of WMTD in a population at high risk for early vascular disease. We studied six ceramides and WMTD using fractional anisotropy (FA) on DTI in healthy relatives of patients with early coronary disease. We have previously shown a high prevalence of white matter hyperintensities (WMH) and significant associations between WMH volumes, FA, and lower cognitive function in healthy relatives. Methods: DTI was acquired with Phillips 3T MRI. FA was measured for 181 regions of the segmented brain using Eve atlas. 48 relevant regions with susceptibility for WMTD were analyzed. Serum ceramides were measured using high performance liquid chromatography. Spearman correlations and GEE linear regression analyses (adjusted for age, sex, race, education and family relatedness) were used. We set the significance level to meet the Bonferroni threshold of 0.00017 (0.05 / 48 regions/6 ceramides). Results: Subjects, N=112, had a mean age of 49± 11 years; education 14 ± 3 years; 49% male; 39% African American, 61% European American). Serum levels for ceramides designated C18:0, C20:0, and C22:0 were significantly negatively correlated with FA in the right fornix (C18:0, R=-0.40, p=1.3 x10 -5 , C20:0, R=-0.41, p= 6.1 x 10 -6 , C22:0, R=-0.33, p=4.3 x10 -4 ). C18:0 was negatively correlated with the left genu of corpus callosum (R=-0.39, p=2.6 x10 -5 ) and right body of corpus callosum (R=-0.31, p=8.5 x10 -4 ). An additional ceramide, C24:0, was correlated with both sides of the posterior limb of internal capsule (left R=0.34, p=2.5 x10 -4 ; right R=0.34, p=2.8 x10 -4 ). All ceramide-FA associations were significant (pConclusions: We show a robust relationship between serum ceramides and WMTD using FA in a middle-aged, cognitively intact at-risk population enriched for early WMH. Thus, serum ceramide levels may reflect subtle alterations in white matter tract microstructure at an early preclinical stage.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TMP91: White Matter Lesion Progression and Cognitive Function Over 5-Years in a Young Susceptible Population
Introduction: Cerebrovascular disease (CVD) and vascular risk factors cluster in families of patients with early-onset coronary artery disease (CAD). In a prior cross-sectional study of 714 healthy middle-aged relatives, we found a high prevalence of early white matter hyperintensity lesions (WMHL) and associated lower cognitive function. Prior WMHL studies have included elderly or demented subjects. Rate of WMHL progression and cognitive decline in quiescent preclinical healthy middle-aged persons remains unknown. Methods: We studied WMHL and cognitive function over 5 years in 20 healthy relatives, age 50-59, of patients with CAD Results: Our 20 participants were: 50% male, 45% African American (AA), average age was 54.1 (SD 1.57) years, 45% with HTN, 15% smokers, and 50% obese. WMHL prevalence was 92%. The average change in WMHL volume was 819 mm 3 (PConclusion: These striking findings are among the first to demonstrate significant quantitative WMHL volume progression and cognitive decline in a healthy middle-aged population over just 5 years, in AA and EA and both sexes. This small pilot study suggests that early quiescent brain white matter lesion progression and early multidimensional cognitive decline can be detected in healthy susceptible populations using state-of-the-art quantitative volumetric imaging techniques.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract TMP91: White Matter Lesion Progression and Cognitive Function Over 5-Years in a Young Susceptible Population
Introduction: Cerebrovascular disease (CVD) and vascular risk factors cluster in families of patients with early-onset coronary artery disease (CAD). In a prior cross-sectional study of 714 healthy middle-aged relatives, we found a high prevalence of early white matter hyperintensity lesions (WMHL) and associated lower cognitive function. Prior WMHL studies have included elderly or demented subjects. Rate of WMHL progression and cognitive decline in quiescent preclinical healthy middle-aged persons remains unknown. Methods: We studied WMHL and cognitive function over 5 years in 20 healthy relatives, age 50-59, of patients with CAD Results: Our 20 participants were: 50% male, 45% African American (AA), average age was 54.1 (SD 1.57) years, 45% with HTN, 15% smokers, and 50% obese. WMHL prevalence was 92%. The average change in WMHL volume was 819 mm 3 (PConclusion: These striking findings are among the first to demonstrate significant quantitative WMHL volume progression and cognitive decline in a healthy middle-aged population over just 5 years, in AA and EA and both sexes. This small pilot study suggests that early quiescent brain white matter lesion progression and early multidimensional cognitive decline can be detected in healthy susceptible populations using state-of-the-art quantitative volumetric imaging techniques.
- 1 May 2012
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1823 (5) , 997-1006
Activation of Stat3 in endothelial cells following hypoxia–reoxygenation is mediated by Rac1 and protein kinase C
- 1 May 2012
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1823 (5) , 997-1006
Activation of Stat3 in endothelial cells following hypoxia–reoxygenation is mediated by Rac1 and protein kinase C
- Open Access
- 1 January 2011
- Published by Springer Nature in BMC Genetics
- Vol. 12 (1) , 50
The impact of FADS genetic variants on ω6 polyunsaturated fatty acid metabolism in African Americans
Arachidonic acid (AA) is a long-chain omega-6 polyunsaturated fatty acid (PUFA) synthesized from the precursor dihomo-gamma-linolenic acid (DGLA) that plays a vital role in immunity and inflammation. Variants in the Fatty Acid Desaturase (FADS) family of genes on chromosome 11q have been shown to play a role in PUFA metabolism in populations of European and Asian ancestry; no work has been done in populations of African ancestry to date.
- 1 January 2011
- Published by Springer Nature in BMC Genetics
- Vol. 12 (1) , 50
Open AccessThe impact of FADS genetic variants on ω6 polyunsaturated fatty acid metabolism in African Americans
Arachidonic acid (AA) is a long-chain omega-6 polyunsaturated fatty acid (PUFA) synthesized from the precursor dihomo-gamma-linolenic acid (DGLA) that plays a vital role in immunity and inflammation. Variants in the Fatty Acid Desaturase (FADS) family of genes on chromosome 11q have been shown to play a role in PUFA metabolism in populations of European and Asian ancestry; no work has been done in populations of African ancestry to date.
- Open Access
- 7 June 2010
- Published by Springer Nature in BMC Medical Genomics
- Vol. 3 (1) , 22
A combined genome-wide linkage and association approach to find susceptibility loci for platelet function phenotypes in European American and African American families with coronary artery disease
The inability of aspirin (ASA) to adequately suppress platelet aggregation is associated with future risk of coronary artery disease (CAD). Heritability studies of agonist-induced platelet function phenotypes suggest that genetic variation may be responsible for ASA responsiveness. In this study, we leverage independent information from genome-wide linkage and association data to determine loci controlling platelet phenotypes before and after treatment with ASA.
- 7 June 2010
- Published by Springer Nature in BMC Medical Genomics
- Vol. 3 (1) , 22
Open AccessA combined genome-wide linkage and association approach to find susceptibility loci for platelet function phenotypes in European American and African American families with coronary artery disease
The inability of aspirin (ASA) to adequately suppress platelet aggregation is associated with future risk of coronary artery disease (CAD). Heritability studies of agonist-induced platelet function phenotypes suggest that genetic variation may be responsible for ASA responsiveness. In this study, we leverage independent information from genome-wide linkage and association data to determine loci controlling platelet phenotypes before and after treatment with ASA.
- 23 November 2008
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 2 (6) , 476-484
Genetic determinants of responsiveness to antiplatelet therapy
- 23 November 2008
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 2 (6) , 476-484
Genetic determinants of responsiveness to antiplatelet therapy
- 1 August 2008
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (8) , 1484-1490
A Novel Variant in the Platelet Endothelial Aggregation Receptor-1 Gene Is Associated With Increased Platelet Aggregability
Objective— Platelet endothelial aggregation receptor-1 (PEAR1) is a recently identified platelet transmembrane protein that becomes activated by platelet contact. We looked for novel genetic variants in PEAR1 and studied their association with agonist-induced native platelet aggregation and with the inhibitory effect of aspirin on platelets. Methods and Results— We genotyped PEAR1 for 10 single nucleotide polymorphisms (SNPs), selected for optimal gene coverage at a density of 4 kb, in 1486 apparently healthy individuals from two generations of families with premature CAD. Subjects had a mean age of 45 years; 62% were white and 38% black. Platelet aggregation to collagen, epinephrine, and ADP was measured in platelet rich plasma, at baseline and after 2 weeks of aspirin (ASA, 81 mg/d), and genotype-phenotype associations were examined separately by ethnicity using multivariable generalized linear models adjusted for covariates. The C allele of SNP rs2768759 [A/C], located in the promoter region of the gene, was common in whites and uncommon in blacks (allele frequency 70.2% versus 17.7%). The C allele was generally associated in both ethnic groups with increased aggregation of native platelets to each agonist. After ASA, the associations were stronger and more consistent and remained significant when post-ASA aggregation was adjusted for baseline aggregation, consistent with a relationship between the C allele and reduced platelet responsiveness to ASA. The PEAR1 SNP explained up to 6.9% of the locus specific genetic variance in blacks and up to 2.5% of the genetic variance in whites after ASA. Conclusion— PEAR1 appears to play an important role in agonist-induced platelet aggregation and in the response to ASA in both whites and blacks.
- 1 August 2008
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (8) , 1484-1490
A Novel Variant in the Platelet Endothelial Aggregation Receptor-1 Gene Is Associated With Increased Platelet Aggregability
Objective— Platelet endothelial aggregation receptor-1 (PEAR1) is a recently identified platelet transmembrane protein that becomes activated by platelet contact. We looked for novel genetic variants in PEAR1 and studied their association with agonist-induced native platelet aggregation and with the inhibitory effect of aspirin on platelets. Methods and Results— We genotyped PEAR1 for 10 single nucleotide polymorphisms (SNPs), selected for optimal gene coverage at a density of 4 kb, in 1486 apparently healthy individuals from two generations of families with premature CAD. Subjects had a mean age of 45 years; 62% were white and 38% black. Platelet aggregation to collagen, epinephrine, and ADP was measured in platelet rich plasma, at baseline and after 2 weeks of aspirin (ASA, 81 mg/d), and genotype-phenotype associations were examined separately by ethnicity using multivariable generalized linear models adjusted for covariates. The C allele of SNP rs2768759 [A/C], located in the promoter region of the gene, was common in whites and uncommon in blacks (allele frequency 70.2% versus 17.7%). The C allele was generally associated in both ethnic groups with increased aggregation of native platelets to each agonist. After ASA, the associations were stronger and more consistent and remained significant when post-ASA aggregation was adjusted for baseline aggregation, consistent with a relationship between the C allele and reduced platelet responsiveness to ASA. The PEAR1 SNP explained up to 6.9% of the locus specific genetic variance in blacks and up to 2.5% of the genetic variance in whites after ASA. Conclusion— PEAR1 appears to play an important role in agonist-induced platelet aggregation and in the response to ASA in both whites and blacks.
- 9 November 2007
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 101 (10) , 1001-1008
Fractalkine Upregulates Intercellular Adhesion Molecule-1 in Endothelial Cells Through CX3CR1 and the Jak–Stat5 Pathway
Fractalkine (FKN) is a membrane-bound chemokine that can be released by proteolysis to produce soluble FKN (s-FKN). FKN and its receptor, CX3CR1, are believed to be important factors in atherosclerosis and may play a role in acute inflammatory responses. Although FKN is expressed on endothelial cells (ECs), CX3CR1 is reported to reside mainly on certain leukocyte populations. RT-PCR and Western blotting demonstrated that both human coronary artery and umbilical vein ECs expressed CX3CR1 mRNA and protein. Confocal microscopy showed that CX3CR1 was located at the cell membrane and to a lesser extent in the cytoplasm. Following exposure of both types of ECs to hypoxia and reoxygenation, FKN expression increased rapidly and s-FKN was shed into the culture medium. The addition of s-FKN protein to cultured ECs resulted in a dose-dependent increase in intercellular adhesion molecule (ICAM)-1 mRNA. Perfusion of mouse hearts with s-FKN protein increased expression of ICAM-1 protein in vascular endothelium. Transfection of ECs with CX3CR1-interfering RNA to knockdown the receptor resulted in decreased ICAM-1 expression after s-FKN stimulation. In addition, when ECs were stimulated with s-FKN, greater adhesion of human neutrophils to the ECs was observed. This increase was ICAM-1 dependent and was blocked by CX3CR1 knockdown. Following exposure to s-FKN, ECs exhibited increased phosphorylation of Jak2 and Stat5 and the ICAM-1 expression induced by s-FKN was blocked by silencing of Stat5 with small interfering RNA. Vascular ECs express both FKN and its receptor CX3CR1. s-FKN is shed from ECs following hypoxia/reoxygenation and acts through CX3CR1 on ECs to increase ICAM-1 expression and promote neutrophil adhesion through activation of the Jak–Stat5 pathway.
- 9 November 2007
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 101 (10) , 1001-1008
Fractalkine Upregulates Intercellular Adhesion Molecule-1 in Endothelial Cells Through CX3CR1 and the Jak–Stat5 Pathway
Fractalkine (FKN) is a membrane-bound chemokine that can be released by proteolysis to produce soluble FKN (s-FKN). FKN and its receptor, CX3CR1, are believed to be important factors in atherosclerosis and may play a role in acute inflammatory responses. Although FKN is expressed on endothelial cells (ECs), CX3CR1 is reported to reside mainly on certain leukocyte populations. RT-PCR and Western blotting demonstrated that both human coronary artery and umbilical vein ECs expressed CX3CR1 mRNA and protein. Confocal microscopy showed that CX3CR1 was located at the cell membrane and to a lesser extent in the cytoplasm. Following exposure of both types of ECs to hypoxia and reoxygenation, FKN expression increased rapidly and s-FKN was shed into the culture medium. The addition of s-FKN protein to cultured ECs resulted in a dose-dependent increase in intercellular adhesion molecule (ICAM)-1 mRNA. Perfusion of mouse hearts with s-FKN protein increased expression of ICAM-1 protein in vascular endothelium. Transfection of ECs with CX3CR1-interfering RNA to knockdown the receptor resulted in decreased ICAM-1 expression after s-FKN stimulation. In addition, when ECs were stimulated with s-FKN, greater adhesion of human neutrophils to the ECs was observed. This increase was ICAM-1 dependent and was blocked by CX3CR1 knockdown. Following exposure to s-FKN, ECs exhibited increased phosphorylation of Jak2 and Stat5 and the ICAM-1 expression induced by s-FKN was blocked by silencing of Stat5 with small interfering RNA. Vascular ECs express both FKN and its receptor CX3CR1. s-FKN is shed from ECs following hypoxia/reoxygenation and acts through CX3CR1 on ECs to increase ICAM-1 expression and promote neutrophil adhesion through activation of the Jak–Stat5 pathway.
- 1 December 2006
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 48 (6) , 320-328
Inhibition of TNF-α Reduces Myocardial Injury and Proinflammatory Pathways Following Ischemia-Reperfusion in the Dog
We examined whether tumor necrosis factor-α (TNF-α) promotes postischemic inflammation and myocardial injury via activation of nuclear factor kappa B (NFκB) in an in vivo canine model. Isoflurane-anesthetized dogs underwent closed-chest balloon occlusion of the anterior descending coronary artery for 90 minutes, followed by reperfusion for 3 hours. Dogs randomly received a soluble TNF inhibitor (etanercept, 0.5 mg/kg intravenously) or saline before occlusion. Collateral blood flow and risk region size (RISK) were measured with radioactive microspheres, infarct size (INF) was measured by triphenyltetrazolium chloride staining, inflammation was measured by tissue myeloperoxidase (MPO) activity, intercellular adhesion molecular-1 (ICAM-1) messenger ribonucleic acid (mRNA) was measured by Northern blotting, and ICAM-1 protein expression was measured by Western blotting. NFκB activation was measured in nuclear extracts by electrophoretic mobility shift assays. INF/RISK was significantly smaller in the etanercept group than in the saline control group after adjusting for collateral flow (P < 0.009 by analysis of covariance, mean reduction in INF/RISK = 40%, 0.32 ± 0.09 versus 0.53 ± 0.09). MPO activity, ICAM-1 mRNA and protein expression, and NFκB binding activity were all significantly reduced in the etanercept group. Administration of a soluble TNF-α inhibitor reduced NFκB activation, ICAM-1 upregulation, and myocardial injury following ischemia-reperfusion. TNF-α appears to play a significant role in vivo in the genesis of postischemic inflammation.
- 1 December 2006
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 48 (6) , 320-328
Inhibition of TNF-α Reduces Myocardial Injury and Proinflammatory Pathways Following Ischemia-Reperfusion in the Dog
We examined whether tumor necrosis factor-α (TNF-α) promotes postischemic inflammation and myocardial injury via activation of nuclear factor kappa B (NFκB) in an in vivo canine model. Isoflurane-anesthetized dogs underwent closed-chest balloon occlusion of the anterior descending coronary artery for 90 minutes, followed by reperfusion for 3 hours. Dogs randomly received a soluble TNF inhibitor (etanercept, 0.5 mg/kg intravenously) or saline before occlusion. Collateral blood flow and risk region size (RISK) were measured with radioactive microspheres, infarct size (INF) was measured by triphenyltetrazolium chloride staining, inflammation was measured by tissue myeloperoxidase (MPO) activity, intercellular adhesion molecular-1 (ICAM-1) messenger ribonucleic acid (mRNA) was measured by Northern blotting, and ICAM-1 protein expression was measured by Western blotting. NFκB activation was measured in nuclear extracts by electrophoretic mobility shift assays. INF/RISK was significantly smaller in the etanercept group than in the saline control group after adjusting for collateral flow (P < 0.009 by analysis of covariance, mean reduction in INF/RISK = 40%, 0.32 ± 0.09 versus 0.53 ± 0.09). MPO activity, ICAM-1 mRNA and protein expression, and NFκB binding activity were all significantly reduced in the etanercept group. Administration of a soluble TNF-α inhibitor reduced NFκB activation, ICAM-1 upregulation, and myocardial injury following ischemia-reperfusion. TNF-α appears to play a significant role in vivo in the genesis of postischemic inflammation.
- 1 July 2005
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (7) , 1395-1400
Signal Transducer and Activator of Transcription 3α and Specificity Protein 1 Interact to Upregulate Intercellular Adhesion Molecule-1 in Ischemic–Reperfused Myocardium and Vascular Endothelium
Objective— Intercellular adhesion molecule-1 (ICAM-1) is upregulated rapidly on endothelial cells during ischemia–reperfusion (I-R) and mediates tissue leukocyte accumulation. The ICAM-1 proximal promoter contains a signal transducer and activator of transcription (Stat) binding motif (gamma-interferon activation site [GAS] sequence), which flanks a specificity protein 1 (Sp1) binding site. We examined the roles of Stat and Sp1 in the regulation of ICAM-1 after myocardial I-R. Methods and Results— Open-chest anesthetized rats underwent coronary artery occlusion for 35 minutes and reperfusion for 0 to 240 minutes. Stat became activated within 15 minutes after reperfusion, primarily in vascular endothelial cells; the activated Stat protein was identified as Stat3 (α-isoform). After phosphorylation on serine 727 (p-S727), Stat3α was found in association with the transcriptional regulator Sp1, and the complex bound to an ICAM-1–GAS probe. ICAM-1 expression increased after I-R and lagged shortly behind Stat3α activation. In cultured human umbilical vein endothelial (HUVE) cells, activation of Stat3α after hypoxia–reoxygenation (H-R) was dependent on the small GTPase Rac1. Transfection of a dominant-negative Stat3 (Y705F) adenovirus or a GAS decoy oligonucleotide reduced ICAM-1 mRNA expression after H-R. Using a reporter gene transfected into HUVE cells, mutation of the GAS element in the ICAM-1 promoter resulted in reduced transcriptional activity after H-R. Sp1 coimmunoprecipitated with p-S727 Stat3 during H-R, and Sp1 or Stat3α interfering RNA markedly reduced ICAM-1 mRNA expression. Conclusion— The Sp1–Stat3 complex appears to play an important role in the upregulation of ICAM-1 transcription after reoxygenation or reperfusion.
- 1 July 2005
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (7) , 1395-1400
Signal Transducer and Activator of Transcription 3α and Specificity Protein 1 Interact to Upregulate Intercellular Adhesion Molecule-1 in Ischemic–Reperfused Myocardium and Vascular Endothelium
Objective— Intercellular adhesion molecule-1 (ICAM-1) is upregulated rapidly on endothelial cells during ischemia–reperfusion (I-R) and mediates tissue leukocyte accumulation. The ICAM-1 proximal promoter contains a signal transducer and activator of transcription (Stat) binding motif (gamma-interferon activation site [GAS] sequence), which flanks a specificity protein 1 (Sp1) binding site. We examined the roles of Stat and Sp1 in the regulation of ICAM-1 after myocardial I-R. Methods and Results— Open-chest anesthetized rats underwent coronary artery occlusion for 35 minutes and reperfusion for 0 to 240 minutes. Stat became activated within 15 minutes after reperfusion, primarily in vascular endothelial cells; the activated Stat protein was identified as Stat3 (α-isoform). After phosphorylation on serine 727 (p-S727), Stat3α was found in association with the transcriptional regulator Sp1, and the complex bound to an ICAM-1–GAS probe. ICAM-1 expression increased after I-R and lagged shortly behind Stat3α activation. In cultured human umbilical vein endothelial (HUVE) cells, activation of Stat3α after hypoxia–reoxygenation (H-R) was dependent on the small GTPase Rac1. Transfection of a dominant-negative Stat3 (Y705F) adenovirus or a GAS decoy oligonucleotide reduced ICAM-1 mRNA expression after H-R. Using a reporter gene transfected into HUVE cells, mutation of the GAS element in the ICAM-1 promoter resulted in reduced transcriptional activity after H-R. Sp1 coimmunoprecipitated with p-S727 Stat3 during H-R, and Sp1 or Stat3α interfering RNA markedly reduced ICAM-1 mRNA expression. Conclusion— The Sp1–Stat3 complex appears to play an important role in the upregulation of ICAM-1 transcription after reoxygenation or reperfusion.